Prices as of 2026/10/30 close
Company comparison
Medipal is the largest by revenue at ¥3.8T, followed by Hanwa (¥2.7T), Matsuda Sangyo (¥687.8B) and ALCONIX (¥219.7B).
ALCONIX has the highest operating margin at 4.4%, 3.0 points above the lowest, Medipal (1.4%).
Revenue growth in the latest results: Matsuda Sangyo +46.7%, ALCONIX +11.5%, Hanwa +4.2%, Medipal +4.0%. For next year, ALCONIX guides for the fastest operating profit growth (+9.8%).
ALCONIX pays the most on average (¥9.53M), ¥2.73M more than Matsuda Sangyo (¥6.81M).
Over the past year the shares moved Matsuda Sangyo +47.0%, Hanwa +42.4%, ALCONIX +40.4%, Medipal +37.9%.
Head-to-head wins17 metrics
One win per metric for the company with the best value. Metrics with no better or worse (P/E, average age, employees) are excluded.
ScaleInvestors
Medipal aheadMedipal 2 : Hanwa 1 : Matsuda Sangyo 0 : ALCONIX 0
Revenue: Medipal ¥3.8T / Hanwa ¥2.7T / Matsuda Sangyo ¥687.8B / ALCONIX ¥219.7B
ProfitabilityInvestors
ALCONIX aheadMedipal 1 : Hanwa 0 : Matsuda Sangyo 1 : ALCONIX 2
Operating margin: Medipal 1.4% / Hanwa 2.2% / Matsuda Sangyo 3.3% / ALCONIX 4.4%
GrowthInvestors
EvenMedipal 0 : Hanwa 2 : Matsuda Sangyo 2 : ALCONIX 1
Revenue growth (YoY): Medipal +4.0% / Hanwa +4.2% / Matsuda Sangyo +46.7% / ALCONIX +11.5%
Stock & balance sheetInvestors
Matsuda Sangyo aheadMedipal 0 : Hanwa 0 : Matsuda Sangyo 2 : ALCONIX 1
Share price, 1 year: Medipal +37.9% / Hanwa +42.4% / Matsuda Sangyo +47.0% / ALCONIX +40.4%
Pay & workforceJob seekers
EvenMedipal 1 : Hanwa 0 : Matsuda Sangyo 0 : ALCONIX 1
Average salary: Medipal ¥8.14M / Hanwa ¥9.26M / Matsuda Sangyo ¥6.81M / ALCONIX ¥9.53M
| Metric | Medipal | Hanwa | Matsuda Sangyo | ALCONIX |
|---|---|---|---|---|
| Revenue | ◎¥3.8T | ¥2.7T | ¥687.8B | ¥219.7B |
| Operating profit | ¥53.2B | ◎¥58.4B | ¥22.4B | ¥9.7B |
| Net income | ◎¥42.5B | ¥38.3B | ¥16.8B | ¥5.6B |
| Metric | Medipal | Hanwa | Matsuda Sangyo | ALCONIX |
|---|---|---|---|---|
| Operating margin | 1.4% | 2.2% | 3.3% | ◎4.4% |
| Net margin | 1.1% | 1.4% | 2.4% | ◎2.5% |
| ROE | — | — | ◎15.4% | 7.5% |
| Revenue per employee | ◎¥20.6B | ¥1.5B | ¥556M | ¥977M |
| Metric | Medipal | Hanwa | Matsuda Sangyo | ALCONIX |
|---|---|---|---|---|
| Revenue growth (YoY) | +4.0% | +4.2% | ◎+46.7% | +11.5% |
| Operating profit growth (YoY) | −4.4% | −5.0% | ◎+77.0% | +40.8% |
| Revenue CAGRlast 5 years | +3.5% | ◎+8.8% | — | — |
| Guidance: revenue growthnext FY plan | +3.3% | ◎+12.7% | +1.8% | +7.0% |
| Guidance: op. profit growthnext FY plan | +3.4% | +6.9% | +7.0% | ◎+9.8% |
| Metric | Medipal | Hanwa | Matsuda Sangyo | ALCONIX |
|---|---|---|---|---|
| Share price, 1 year | +37.9% | +42.4% | ◎+47.0% | +40.4% |
| Share price, 3 months | +14.6% | +7.5% | +15.5% | ◎+17.2% |
| P/E (trailing)lower = cheaper | — | — | 9.2x | 16.2x |
| Equity ratio | — | — | ◎52.3% | 35.9% |
| Share price (close) | ¥3,441 | ¥1,829 | ¥5,970 | ¥3,015 |
◎ marks the best value for each metric. Revenue and profit are from the latest full-year earnings release; share prices are closing-price references; P/E = latest close ÷ trailing EPS. For banks and some other financials, revenue means ordinary income.
| Metric | Medipal | Hanwa | Matsuda Sangyo | ALCONIX |
|---|---|---|---|---|
| Average salary | ¥8.14M | ¥9.26M | ¥6.81M | ◎¥9.53M |
| Starting salary (monthly) | — | ◎¥320,000 | ¥250,000 | ◎¥320,000 |
| Average tenure | ◎19.8 yrs | 11.5 yrs | 12.1 yrs | 10.7 yrs |
| Average age | 48.6 | 37.4 | 39.7 | 44.4 |
| Employees | 185 | 1,745 | 1,238 | 225 |
Average salary is for the reporting (parent) company and is affected by average age and job mix. Holding companies with few employees are left out of the salary comparison.
Close (Oct 30, 2026)
¥3,441+37.9% (1Y)
Medipal +37.9% over 1Y. Compared: Hanwa +42.4%, Matsuda Sangyo +47.0%, ALCONIX +40.4%.
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Each line shows the % change from the start of the period. Updated Oct 30, 2026.
Medipal3 segments
Hanwa6 segments
Matsuda Sangyo2 segments
ALCONIX4 segments
AAverage annual salary from the securities filings: ALCONIX ¥9.53M, Hanwa ¥9.26M, Medipal ¥8.14M, Matsuda Sangyo ¥6.81M. ALCONIX pays the most. Averages also depend on staff age and job mix, so check the average age too (Medipal 48.6, Hanwa 37.4, Matsuda Sangyo 39.7, ALCONIX 44.4).
ARevenue in the latest results: Medipal ¥3.8T, Hanwa ¥2.7T, Matsuda Sangyo ¥687.8B, ALCONIX ¥219.7B. Medipal is the largest by revenue at ¥3.8T, followed by Hanwa (¥2.7T), Matsuda Sangyo (¥687.8B) and ALCONIX (¥219.7B).
AOperating margins: ALCONIX 4.4%, Matsuda Sangyo 3.3%, Hanwa 2.2%, Medipal 1.4%. ALCONIX turns the highest share of sales into operating profit.
AShare price change over the past year (closing prices, for reference): Matsuda Sangyo +47.0%, Hanwa +42.4%, ALCONIX +40.4%, Medipal +37.9%. Matsuda Sangyo has risen the most.
Comparing 4 companies (up to 4)
Sources: earnings releases (kessan tanshin), annual securities reports and other public information. Share prices are closing-price references, not real-time. Our data may contain errors; investment decisions are your own responsibility.
